Welcome to GTx, a biopharmaceutical company dedicated to the discovery, development, and
commercialization of small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions.
Our recognized scientific expertise is in the discovery and development of novel, selective small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions. Click to learn more about our products in development.
GTx is a biopharmaceutical company dedicated to the discovery, development and commercialization of drug candidates. Click to learn more about the GTx management team.
GTx, Inc. to Report Second Quarter 2014 Financial Results on August 5, 2014 
GTx Reports Positive Clinical Data from Open Label Phase 2 Study of Enobosarm in Patients with Androgen and Estrogen Receptor Positive Metastatic Breast Cancer
GTx Announces Webcast of Corporate Presentation at Jefferies 2014 Global Healthcare Conference